Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Umbra Applied Technologies is a diversified technology holding company that operates a specialized biotechnology division focused on infectious disease prevention and medical innovation. The company develops advanced antimicrobial coatings, medical devices, and hygiene products designed to mitigate the spread of pathogens in healthcare and commercial environments. Its flagship H-Shield technology provides long-lasting antimicrobial surface protection, while the Ossis and Hygeia lines focus on orthopedic solutions and medical-grade personal protective equipment. By leveraging defense-grade research and development, UAT aims to deliver high-performance healthcare solutions for both clinical and consumer markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Umbra Applied Technologies.